FOLX Health operates a digital healthcare platform designed specifically for the LGBTQIA+ community. Founded in 2020 by A.G. Breitenstein, the company delivers virtual care across a range of health services including gender-affirming hormone therapy, HIV pre-exposure prophylaxis (PrEP), sexually transmitted infection testing, mental health and therapy services, primary care, sexual and reproductive health, and fertility services. The platform operates nationwide across the United States and accepts insurance from major providers including Cigna, Evernorth, and BlueCross BlueShield.
FOLX Health distinguishes itself through its internal composition: 81% of its clinicians identify as LGBTQIA+, and the entire executive team comprises members of the community it serves. This reflects the company's foundational premise that healthcare delivery for LGBTQIA+ patients benefits from care designed by and for the community rather than retrofitted from existing models. The platform aims to address documented barriers, with research cited suggesting that roughly 70% of transgender individuals experience discrimination in healthcare settings.
The company has received external recognition from TIME and Fast Company for its approach to transforming healthcare delivery for LGBTQIA+ communities. By consolidating multiple care services on a single platform staffed predominantly by affirming clinicians, FOLX Health seeks to reduce friction and stigma in accessing healthcare.
